One group was given the GLP-1 semaglutide consistently for the entire four-month study period
Research Studies and Clinical Trials Several studies and clinical trials have explored the potential of semaglutide in managing fibroids
According to some research, those who consume more flavonoids in their diets than those who consume the least have a 47% increased risk of cardiovascular disease (579)
For patients exploring weight management with diabetes medications considering gastric sleeve, gastric bypass, duodenal switch or SADI surgery
These studies presented several limitations, in fact, they did not adjust for potential confounding variables such as genetic factors, sun exposure, vitamin D intake
Emerging medications and the expanding toolbox The field is evolving rapidly